Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
572 | Circular Farmaceutica | journal | 0.100 Q4 | 3 | 11 | 84 | 118 | 0 | 73 | 0.00 | 10.73 | |
571 | Contract Pharma | trade journal | 0.100 Q4 | 4 | 0 | 143 | 0 | 0 | 143 | 0.00 | 0.00 | |
570 | EBR - European Biopharmaceutical Review | journal | 0.100 Q4 | 6 | 0 | 96 | 0 | 0 | 81 | 0.00 | 0.00 | |
569 | Innovations in Pharmaceutical Technology | trade journal | 0.100 Q4 | 9 | 0 | 100 | 0 | 0 | 98 | 0.00 | 0.00 | |
568 | Manufacturing Chemist | trade journal | 0.100 Q4 | 6 | 82 | 215 | 104 | 0 | 215 | 0.00 | 1.27 | |
567 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 0 | 53 | 0 | 0 | 53 | 0.00 | 0.00 | |
566 | Pharmaceutical Outsourcing | journal | 0.100 Q4 | 7 | 0 | 135 | 0 | 2 | 119 | 0.00 | 0.00 | |
565 | Pharmaceutisch Weekblad | journal | 0.100 Q4 | 9 | 365 | 1354 | 0 | 8 | 701 | 0.00 | 0.00 | |
564 | Pharmacy Times | trade journal | 0.100 Q4 | 8 | 250 | 537 | 1180 | 2 | 104 | 0.01 | 4.72 | |
563 | Pharmazeutische Zeitung | journal | 0.100 Q4 | 7 | 905 | 2371 | 285 | 2 | 1107 | 0.00 | 0.31 | |
562 | PZ Prisma | journal | 0.100 Q4 | 5 | 35 | 102 | 691 | 0 | 90 | 0.00 | 19.74 | |
561 | Adverse Drug Reaction Bulletin | journal | 0.101 Q4 | 8 | 6 | 20 | 197 | 0 | 17 | 0.00 | 32.83 | |
560 | Drug Topics | journal | 0.101 Q4 | 8 | 163 | 504 | 48 | 2 | 30 | 0.01 | 0.29 | |
559 | GMP Review | trade journal | 0.101 Q4 | 2 | 19 | 43 | 38 | 0 | 23 | 0.00 | 2.00 | |
558 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.101 Q4 | 50 | 1 | 39 | 50 | 1 | 31 | 0.03 | 50.00 | |
557 | Japanese Journal of Neuropsychopharmacology | journal | 0.101 Q4 | 12 | 0 | 26 | 0 | 2 | 24 | 0.00 | 0.00 | |
556 | Journal of International Peacekeeping | journal | 0.101 Q4 | 14 | 9 | 34 | 259 | 1 | 32 | 0.00 | 28.78 | |
555 | Pharmakeftiki | journal | 0.101 Q4 | 6 | 11 | 42 | 459 | 2 | 38 | 0.05 | 41.73 | |
554 | Drug Development and Delivery | trade journal | 0.102 Q4 | 12 | 74 | 198 | 370 | 8 | 107 | 0.05 | 5.00 | |
553 | Oral Therapeutics and Pharmacology | journal | 0.102 Q4 | 6 | 6 | 30 | 149 | 2 | 30 | 0.06 | 24.83 | |
552 | Pharmaceutical Discovery, Development and Manufacturing Forum 2018 - Core Programming Area at the 2018 AIChE Annual Meeting | conference and proceedings | 0.102 | 1 | 0 | 14 | 0 | 0 | 13 | 0.00 | 0.00 | |
551 | Pharmaceutical Engineering | journal | 0.102 Q4 | 18 | 0 | 96 | 0 | 6 | 54 | 0.07 | 0.00 | |
550 | Pharmaceutical Technology Europe | journal | 0.102 Q4 | 19 | 18 | 309 | 122 | 11 | 256 | 0.05 | 6.78 | |
549 | PharmacoVigilance Review | journal | 0.102 Q4 | 2 | 0 | 20 | 0 | 2 | 15 | 0.17 | 0.00 | |
548 | Pharmazeutische Industrie | journal | 0.102 Q4 | 19 | 0 | 567 | 0 | 13 | 539 | 0.02 | 0.00 | |
547 | Cancer Drug Discovery and Development | book series | 0.103 Q4 | 8 | 14 | 115 | 1651 | 49 | 7 | 0.59 | 117.93 | |
546 | Frontiers in Anti-infective Drug Discovery | book series | 0.103 Q4 | 3 | 1 | 8 | 141 | 0 | 7 | 0.00 | 141.00 | |
545 | S.T.P. Pharma Pratiques | journal | 0.103 Q4 | 10 | 0 | 9 | 0 | 1 | 9 | 0.00 | 0.00 | |
544 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.104 Q4 | 7 | 2 | 16 | 24 | 3 | 10 | 0.14 | 12.00 | |
543 | 2017 International Conference on Environmental Pollution and Public Health, EPPH 2017 | conference and proceedings | 0.105 | 2 | 0 | 6 | 0 | 1 | 5 | 0.00 | 0.00 | |
542 | Arzneimitteltherapie | journal | 0.105 Q4 | 6 | 137 | 483 | 1137 | 7 | 193 | 0.02 | 8.30 | |
541 | European Journal of Oncology Pharmacy | journal | 0.105 Q4 | 6 | 6 | 28 | 148 | 22 | 22 | 1.16 | 24.67 | |
540 | Japanese Journal of Clinical Pharmacology and Therapeutics | journal | 0.105 Q4 | 8 | 40 | 108 | 605 | 6 | 105 | 0.04 | 15.13 | |
539 | RSC Drug Discovery Series | book series | 0.105 Q4 | 13 | 12 | 256 | 1740 | 75 | 36 | 0.34 | 145.00 | |
538 | Drug Delivery System | journal | 0.106 Q4 | 9 | 62 | 188 | 1075 | 9 | 123 | 0.06 | 17.34 | |
537 | Frontiers in Clinical Drug Research - Anti Allergy Agents | book series | 0.106 Q4 | 1 | 6 | 7 | 732 | 0 | 3 | 0.00 | 122.00 | |
536 | Hacettepe University Journal of the Faculty of Pharmacy | journal | 0.106 Q4 | 9 | 10 | 31 | 460 | 2 | 31 | 0.10 | 46.00 | |
535 | International Journal of Computational Biology and Drug Design | journal | 0.107 Q4 | 16 | 40 | 70 | 1069 | 22 | 57 | 0.37 | 26.73 | |
534 | Pharmaceuticals Policy and Law | journal | 0.107 Q4 | 11 | 0 | 31 | 0 | 4 | 29 | 0.05 | 0.00 | |
533 | Journal of Medical Marketing | journal | 0.108 Q4 | 20 | 0 | 10 | 0 | 4 | 7 | 0.00 | 0.00 | |
532 | Klinicka Farmakologie a Farmacie | journal | 0.108 Q4 | 5 | 34 | 89 | 850 | 4 | 85 | 0.05 | 25.00 | |
531 | National Toxicology Program technical report series | journal | 0.108 | 22 | 2 | 7 | 0 | 1 | 7 | 0.20 | 0.00 | |
530 | Pharmaceutical Journal | journal | 0.108 Q4 | 28 | 442 | 1571 | 2723 | 74 | 1370 | 0.06 | 6.16 | |
529 | Side Effects of Drugs Annual | book series | 0.108 Q4 | 9 | 43 | 148 | 2116 | 44 | 3 | 0.35 | 49.21 | |
528 | Antibodies | journal | 0.112 Q4 | 42 | 70 | 120 | 5440 | 498 | 119 | 4.69 | 77.71 | |
527 | Japanese Journal of Chemotherapy | journal | 0.112 Q4 | 13 | 37 | 95 | 757 | 8 | 95 | 0.06 | 20.46 | |
526 | Pharmacoeconomics - Spanish Research Articles | journal | 0.113 Q4 | 6 | 0 | 17 | 0 | 3 | 16 | 0.00 | 0.00 | |
525 | Drugs of the Future | journal | 0.115 Q4 | 46 | 75 | 251 | 2235 | 33 | 250 | 0.14 | 29.80 | |
524 | Environmental Arsenic in a ChangingWorld - 7th International Congress and Exhibition Arsenic in the Environment, 2018 | conference and proceedings | 0.115 | 3 | 0 | 212 | 0 | 15 | 206 | 0.07 | 0.00 | |
523 | European Pharmaceutical Review | trade journal | 0.115 Q4 | 9 | 0 | 143 | 0 | 22 | 140 | 0.04 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®